ArticleAIDS (London, England)2018

CD8+ T cells: mechanistic target of rapamycin and eukaryotic initiation factor 2 in elite HIV-1 control.

Tinashe Nyanhete et al.PubMed ↗Publisher ↗

No numbers read from the abstract.